{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Galarubicin",
  "nciThesaurus": {
    "casRegistry": "140637-86-1",
    "chebiId": "",
    "chemicalFormula": "C30H32FNO13",
    "definition": "An anthracycline derivative with antineoplastic activity developed to circumvent doxorubicin resistance.",
    "fdaUniiCode": "6F39648E92",
    "identifier": "C81422",
    "preferredName": "Galarubicin",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C1594"
    ],
    "synonyms": [
      "(8S,10S)-10-((2.6-Dideoxy-2-fluoro-alpha-L-talopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione 8(sup 2)-ester with Beta-alanine",
      "GALARUBICIN",
      "Galarubicin"
    ]
  }
}